Targeting Nrf2/KEAP1 signaling pathway using bioactive compounds to combat mastitis.

Area of Science:

• Veterinary Medicine
• Molecular Biology
• Biochemistry

Background:

• Mastitis, a mammary gland inflammation, significantly impacts dairy production and animal health.
• Key mastitis biomarkers include oxidative stress, apoptosis, inflammation, and suppressed immunity.
• The Nrf2/KEAP1 pathway regulates antioxidant responses and cellular defense.

Purpose of the Study:

• To review the therapeutic potential of targeting the Nrf2/KEAP1 pathway for mastitis.
• To explore bioactive compounds that can mitigate mastitis by modulating Nrf2/KEAP1 signaling.

Main Methods:

• Literature review of recent studies on mastitis and Nrf2/KEAP1 signaling.
• Analysis of Nrf2 pathway activation by bioactive compounds.
• Examination of Nrf2's role in inhibiting pro-inflammatory pathways like NF-kB.

Main Results:

• Nrf2 activation by bioactive compounds reduces oxidative stress and inflammation in mastitis.
• Nrf2 inhibits NF-kB signaling, a key pro-inflammatory pathway in mammary glands.
• Targeting Nrf2/KEAP1 shows promise for mastitis prevention and treatment.

Conclusions:

• The Nrf2/KEAP1 pathway is a promising therapeutic target for mastitis.
• Bioactive compounds modulating Nrf2/KEAP1 can combat mastitis-induced oxidative stress and inflammation.
• Further research into Nrf2-targeting therapies could significantly benefit dairy animal health.